assessing immune biomarkers of response to anthracyclines in breast cancer
Published 3 years ago • 68 plays • Length 16:58Download video MP4
Download video MP3
Similar videos
-
1:02:45
biomarkers in breast cancer: current practice, opportunities and unmet needs
-
1:02:45
biomarkers in breast cancer: current practice, opportunities and unmet needs
-
1:02:45
biomarkers in breast cancer: current practice, opportunities and unmet needs
-
1:02:45
biomarkers in breast cancer: current practice, opportunities and unmet needs
-
30:40
prediction of response to anthracycline-based chemotherapy in early breast cancer
-
57:52
biomarkers for treatment and progression | 2021-2022 embrace mbc virtual forum series
-
38:46
a multi-omic single cell and spatial atlas of breast cancer reveals stromal suppression
-
0:42
can anthracyclines be omitted in tnbc?
-
6:36
targeted oncology biomarker solutions in the elucidation of inflammatory breast cancer mechanisms
-
7:23
san antonio breast cancer symposium 2008: new biomarker predicts anthracycline response.
-
4:20
immune function marker does not predict benefit of trastuzumab in her breast cancer patients
-
3:43
tumor-infiltrating lymphocytes act as prognostic biomarkers in advanced breast cancer
-
6:27
adding anthracyclines to the adjuvant treatment of breast cancer - data review and practical implica
-
42:10
detection of mutations from liquid biopsies - applications in cancer diagnostics
-
1:26
the search for biomarkers in metastatic breast cancer
-
23:52
workshop: clinical research "selecting rational biomarkers for clinical and translational studies"
-
45:34
2021 oneoncology | advancing precision oncology in the community | liquid biopsy
-
46:33
understanding biomarker testing
-
22:36
cde series 9 - emerging role of genomic testing and liquid biopsy in breast cancer